Month: February 2017

Roadshow buyouts becoming a ‘thing’

Mauser Group B.V. was expected to go public on Thursday and raise roughly $265mm if its 12.6mm offering was priced at the mid-point of the $20-$22 range. Instead, the PE firm, Clayton, Dubilier & Rice (CD&E), decided to sell the supplier of industrial rigid packaging products and reconditioning services to Stone Canyon Industries for an all-cash transaction of[…]

02.07.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Coherus Biosciences Symbol: CHRS Price: Last trade $26.65 Description: Re-offer range $24.00-$25.00 Trade Date: 2/8 Shares: 4.7 million Underwriter(s)J.P. Morgan, Citigroup,[…]

2.06.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Antero Midstream Partners LP Symbol: AM Price: Last trade $33.89 Description: Re-offer range $33.20-$33.55 Trade Date: 2/7 Shares: 5 million Underwriter(s)Barclays,[…]

A Snapshot…of Snap’s S-1 filing

Snap, Inc. made its grand S-1 entrance on Thursday (2/2) with an official filing with the SEC. Talking heads instantly dissected the 200+ page document–everything from its financials to its user growth averages and ending with a potential valuation question. If we had to describe the filing in one word…it would be “aggressive”.  There’s a lot to digest, breakdown and[…]

Snap, Hamilton Lane highlight new filings in IPO Pipeline

NEW FILINGS Company: Hamilton Lane Incorporated Symbol: HLNE Price: TBD Description: They are a global private markets investment solutions provider with approximately $40 billion of assets under management and approximately $274 billion of assets under advisement. Trade Date: TBD Shares: TB Underwriter(s): J.P. Morgan, Morgan Stanley Co Manager(s): Goldman Sachs & Co., Keefe Bruyette &[…]

2.2.2017 Secondary announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Neos Therapeutics Symbol: NEOS Price: Last trade $5.80 Description: Re-offer $5.00 Trade Date: 2/3 Shares: 5 million Underwriter(s)Cowen & Co., BMO[…]

02.01.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Smart Sand *amendment since this a.m. announcement Symbol: SND Price: Last Trade $17.40 Trade Date: 2/2 Shares: 5 million **increased from[…]

IPO Boutique announces a Secondary (2.1.17am)

SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter  Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.  For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a[…]

Scroll to top
error: Content is protected !!